The number of businesses and medical clinics advertising stem cell-based therapies has skyrocketed in the U.S. over the past five years, according to a study published in Cell Stem Cell Nov. 4.
Biologics
Over the past few decades, rates of spinal fusions have steadily risen. However, pseudarthrosis rates— an indicator of unsuccessful spinal fusion — have not improved enough in the past 20 years to reduce the overall non-unions. With a growing number of…
Pacira Biosciences reported an uptick in total sales and its Exparel injectable analgesic during the third quarter.
Pacira Biosciences reached a milestone with its patent for the Exparel injectable analgesic, the company said Nov. 2.
Stockholders approved Bioventus' planned acquisition of Misonix.
Advertisement
Medtronic will no longer distribute Aziyo Biologics' cellular bone matrix products.
Goldman Sachs listed DiscGenics CEO Flagg Flanagan as one of the 100 Most Intriguing Entrepreneurs of 2021, according to an Oct. 18 news release.
Bone Therapeutics appointed a five-person scientific advisory board for guidance on developing induced pluripotent stem cell-derived mesenchymal stromal cell, the company said Oct. 12.
Pacira BioSciences signed an agreement to acquire Flexion Therapeutics, according to an Oct. 11 news release.
Virginia Beach, Va.-based LifeNet Health launched the ViviGen minimally invasive surgery delivery system.